The NASA Translational Research Institute (NTRI) will implement a bench-to-spaceflight model, moving results or methods from laboratory experiments or clinical trials to point-of-care astronaut health and performance applications, the US space agency said in a statement.
The goal of the research is to produce promising new approaches, treatments, countermeasures or technologies that have practical application to spaceflight.
"Its fitting on the 47th anniversary of humanitys first moon landing that were announcing a new human spaceflight research institute that will help reduce risks for our astronauts on the next giant leap - our Journey to Mars, said Marshall Porterfield, NASAs Director of Space Life and Physical Sciences Research and Applications.
Set up under the Translational Research Institute Cooperative Agreement, overseen by NASAs Human Research Programme, the new institute is lated to begin functioning from October 1.
NASA will join with Baylor College of Medicine in Houston to operate the new institute, the statement added.
Translational research is an interdisciplinary model of research that focuses on translating fundamental research concepts into practice, with appreciable health outcomes.
Translational research has the potential to move solutions into practical application much faster than traditional research approaches.
To that end, the NASA Translational Research Institute would maintain research leadership in translational human performance, biomedical, environmental, and cognitive and behavioural science, and foster greater involvement of the science community in accomplishing the agencys human exploration goals.
The institute also would provide opportunities for scientists to gain experience in research laboratories, within and external to NASA, and apply their knowledge and expertise to reducing human exploration health and performance risks.
This website uses cookies.